Skipping Adjuvant Radiotherapy May Not Impact Risk of Recurrence or Progression in Patients with Low-risk DCIS
MRI and a DCIS gene profile were used to stratify patients for treatment SAN ANTONIO – Patients with low-risk...
MRI and a DCIS gene profile were used to stratify patients for treatment SAN ANTONIO – Patients with low-risk...
SAN ANTONIO – Comprehensive profiling of fusion RNAs present in a large cohort of metastatic breast tumors revealed unique...
Study examined pregnancy and cancer outcomes among patients who paused endocrine therapy to conceive SAN ANTONIO – Using fertility...
Treatment for metastatic disease may last indefinitely, amplifying the need for effective interventions SAN ANTONIO – Among patients with...
Results are from a five-year follow-up; long-term study is needed SAN ANTONIO – Almost all postmenopausal patients aged 50-69...
Treatment de-escalation may be an option for patients whose lymph nodes become cancer free after neoadjuvant treatment SAN ANTONIO...
SAN ANTONIO – A combination of two HER2-targeted drugs, tucatinib (Tukysa) and trastuzumab emtansine (Kadcyla, T-DM1), extended progression-free survival...
SAN ANTONIO – The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an...
AACR expresses appreciation to Monica Bertagnolli, MD, for her stewardship of NCI before becoming NIH director in early November PHILADELPHIA...
PHILADELPHIA – The American Association for Cancer Research (AACR) and the St. Baldrick’s Foundation today announced that Alanna Joyce...